Bárbara Cristina Silva Holanda Queiroz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bárbara Cristina Silva Holanda Queiroz has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Silva de Almeida
Department of Pharmacy, Universidade Federal do Rio Grande do Norte, Natal-RN 59012-570, Brazil
1 shared publication - Attilio Converti
Department of Civil, Chemical and Environmental Engineering, Pole of Chemical Engineering, University of Genoa, Via Opera Pia 15, 16145 Genoa, Italy
1 shared publication - Fernanda Ílary Costa Duarte
Hospital Pharmacy, Hospital João Machado, Natal 59012-570, Brazil
1 shared publication - Ingrid da Silva Albuquerque
Department of Pharmacy, Universidade Federal do Rio Grande do Norte, Natal-RN 59012-570, Brazil
1 shared publication - Verônica da Silva Oliveira
Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil
1 shared publication - Ádley Antonini Neves de Lima
Department of Pharmacy, Federal University of Rio Grande do Norte, Natal 59012-570, RN, Brazil
1 shared publication
Latest Publications
- Open Access
- 30 September 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (10) , 933
Therapeutic Applications of Solid Dispersions for Drugs and New Molecules: In Vitro and In Vivo Activities
This review aims to provide an overview of studies that address the use, in therapeutic applications, of solid dispersions (SDs) with biological activities in vitro and/or in vivo mainly made up of polymeric matrices, as well as to evaluate the bioactive activity of their constituents. This bibliographic survey shows that the development of solid dispersions provides benefits in the physicochemical properties of bioactive compounds, which lead to an increase in their biological potential. However, despite the reports found on solid dispersions, there is still a need for biological assay-based studies, mainly in vivo, to assist in the investigation and to devise new applications. Therefore, studies based on such an approach are of great importance to enhance and extend the use of solid dispersions in the most diverse therapeutic applications.
- 30 September 2020
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (10) , 933
Open AccessTherapeutic Applications of Solid Dispersions for Drugs and New Molecules: In Vitro and In Vivo Activities
This review aims to provide an overview of studies that address the use, in therapeutic applications, of solid dispersions (SDs) with biological activities in vitro and/or in vivo mainly made up of polymeric matrices, as well as to evaluate the bioactive activity of their constituents. This bibliographic survey shows that the development of solid dispersions provides benefits in the physicochemical properties of bioactive compounds, which lead to an increase in their biological potential. However, despite the reports found on solid dispersions, there is still a need for biological assay-based studies, mainly in vivo, to assist in the investigation and to devise new applications. Therefore, studies based on such an approach are of great importance to enhance and extend the use of solid dispersions in the most diverse therapeutic applications.